• Is HFNC noninferior to NIV for Acute Respiratory Failure?

  • Jan 24 2025
  • Length: 32 mins
  • Podcast

Is HFNC noninferior to NIV for Acute Respiratory Failure?

Listen for free

View show details

  • Summary

  • Both NIV and HFNC are used to treat patients with acute respiratory failure. Current guidelines recommend NIV for acute respiratory failure caused by COPD and acute cardiogenic pulmonary edema. However, NIV may be hard for some patients to tolerate. When compared to low-flow oxygen therapy, HFNC has been shown to improve oxygenation, improve alveolar recruitment, and enhance clearance of secretions. HFNC may be easier to use and tolerate than NIV, but there remains uncertainty regarding the effectiveness of HFNC compared to NIV for acute hypoxemic respiratory failure. In this podcast, we discuss the RENOVATE trial that sought to compare HFNC with NIV on rates of intubation in patients with acute respiratory failure.
    Show More Show Less
Show More Show Less

What listeners say about Is HFNC noninferior to NIV for Acute Respiratory Failure?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available